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ihe Weasel Clause
xcluding Patients From
oor-to-Balloon Analyses
umerous broad-based studies, including that from the U.S.
ational Registry of Myocardial Infarction (1), have convincingly
hown a direct relationship between door-to-balloon time and
n-hospital mortality for patients treated with primary percutane-
us coronary intervention for ST-segment elevation myocardial
nfarction. Presumably, the principal reason for this observation is
hat ischemic time, and hence infarct size, is limited by early
eperfusion (2). Some data suggest, however, that the reduction in
ortality is due to greater overall quality of care rather than
eperfusion time per se (3).
Fast door-to-balloon times require a multidisciplinary system
pproach. This has been carefully studied and noted to include,
hen possible, paramedic electrocardiogram transfer to alert the
eceiving team, single-page activation of the on-call team, and a
uality control program with system feedback, all of which, to a
arge degree, are under control of the emergency medical services–
mergency room–interventional cardiology “system.” There are a
umber of factors that might adversely affect door-to-balloon time
hat are beyond the control of the team, including difficult consent
rocess, need to exclude serious comorbidities that might influence
oncomitant drug therapy for primary percutaneous coronary
ntervention (e.g., intracranial hemorrhage for a patient found
own and resuscitated), and cardiac arrest occurring between the
ime of emergency department arrival and initiation of percutane-
us intervention. Some other potential causes for delay are well
ithin the control of the interventionalist team, including
eekend/off-hours staffing, skillful vascular access, and rapid
annulation of the infarct-related artery.
Door-to-balloon-time metrics can be appropriately used both
or internal quality control and for external comparison. For
nternal quality control, the hospital might choose to exclude
atients with certain comorbidities, and as long as they are
onsistent in doing so, they can track improvements in outcome
nd even compare among operators. For external comparison,
owever, particularly in the “pay for performance” era, the exclu-
ion rules must be applied uniformly. Ideally, reasons for exclusion
hould not be subjective or easily “gamed.” Few, it would seem,
ould argue with these ground rules.
Therefore, when the most recent ACC NCDR-revised reasons
or patient exclusion in door-to-balloon time analysis were an-
ounced (4)—most notably difficult vascular access or difficulty in
rossing the culprit lesion, both highly subjective and easily used to
xplain a poor door-to-balloon time—it struck us as inappropriate.
n fact, when we heard these exclusions described, our initial
ommentary was “this would allow for an abrogation of responsi-
ility” or, more colorfully, “this is a weasel clause!” dPhysicians are under fire from multiple quarters due to per-
eived lack of integrity arising from the activities of some of our
olleagues. We call for a retraction of such subjective and easily
anipulated exclusions immediately. Should that not be possible,
r meet with illogical resistance, at a minimum, each site should be
equired to report the percentage of patients with ST-segment
levation myocardial infarction that were excluded from “report-
ble” door-to-balloon time.
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eply
s contributors to the NCDR (National Cardiovascular Data
egistry), we read the letter by Ellis and colleagues with interest.
he NCDR has long been dedicated to the measurement and
mprovement in care quality. Undoubtedly, these goals are best
romoted when the measures used to characterize quality are as
alid as possible.
We agree regarding the distinction between measures used for
he purposes of quality improvement and those intended for the
urposes of external accountability. Indeed, the American College
f Cardiology/American Heart Association (ACC/AHA) Perfor-
ance Measures Task Force methodology explicitly acknowledges
his dichotomy (1). Measures used for the purposes of account-
bility must rise to a particularly high standard with respect to
alidity, burden of data collection, and susceptibility to “gaming.”
The specific issue Ellis and colleagues raise is the exclusion in the
eperfusion measure for patient-centered reasons for delaying therapy
n the NCDR CathPCI Registry. Clinically appropriate reasons for
elays in reperfusion therapy are numerous. Indeed, enumerating
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November 16, 2010:1763–5hem completely is impractical. The NCDR CathPCI Registry
eperfusion measures allow for exclusions for patient-centered reasons
or delay (e.g., the need for a decision-altering diagnostic test prior to
ossible primary percutaneous coronary intervention). Although the
easures may include examples, they do not include specific lists of
hese reasons. Such exclusions were integrated into the measure to
cknowledge the fact that high-quality clinicians providing the best
are will, on occasion, face situations where their delivery of reperfu-
ion therapy is delayed for clinically appropriate reasons. As Ellis and
olleagues point out, the flexibility intrinsic to this exclusion may
reate opportunities for gaming.
Although we believe that the high standards of medical profes-
ionals protect the integrity of the measures to some extent, we are
ot so naive to assume that professional integrity alone will
liminate gaming. Unfortunately, however, addressing this issue by
emoving the exclusion as proposed by Ellis and colleagues raises
ubstantial problems of its own by undermining the clinical face
alidity of the measure. The absence of such exclusions creates
ther compelling arguments—namely, that centers that care for
articularly complex patients, where clinically reasonable delays are
ore common—are disproportionately penalized. Indeed, before
he Department of Health and Human Services’ Centers for
edicare and Medicaid Services/Joint Commission measure in-
orporated this exclusion, such complaints were among the most
ommon causes for objection to the reperfusion measures (Jo
eBuhr, Colorado Foundation for Medical Care, personal
ommunication, July 2010).
This dilemma, among the many complex issues surrounding
easuring reperfusion quality, was addressed explicitly by an
CC/AHA Writing Group comprised of experienced clinicians
nd experts in performance measurement (2). This writing group
oncluded that this exclusion is important, despite its limitations.
his opinion is reflected in the current ACC/AHA performance
easures for acute myocardial infarction (3).
Further, the Writing Group recommended: 1) surveillance for
he proportion of cases where exclusions are noted, including the
istribution of the exclusions by institution; and 2) audit of the
linical appropriateness of exclusions both in a targeted manner
i.e., among institutions with the highest numbers of excluded
ases) as well as randomly.
To this point, NCDR metrics have been used predominantly for
uality improvement. Although some of the metrics reported to
egistry participants are not intended for accountability purposes,
thers—including the time-to–primary percutaneous coronary inter-
ention metric in question—might reasonably be viewed as useful in
his regard. As this occurs, we agree with Ellis and colleagues that
reater scrutiny of exclusions, consistent with the recommendations
y the ACC/AHA Writing Group is warranted.
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erial Intravascular
ltrasound Examinations
nd Clinical Outcome
e read with interest the paper by Nicholls et al. (1) investigating
he relationship between intravascular ultrasound (IVUS)–derived
easures of atherosclerosis (baseline and change in percent ather-
ma volume) and cardiovascular outcomes (death, myocardial
nfarction, and coronary revascularization). Based on the study
esign, however, it seems difficult to determine the relationship
etween change in percent atheroma volume and death or myo-
ardial infarction because IVUS examination at follow-up is often
issing in patients with such clinical events. To clarify this point,
t would be of great help if the investigators would provide data
egarding how many patients died or had myocardial infarction
nd how long patients underwent follow-up for occurrence of
ardiovascular outcomes after follow-up IVUS examination.
In addition, Figure 1 of their paper (1) shows a striking increase
n cardiovascular events between 500 and 600 days (repeat IVUS
xamination period), suggesting angiographically/IVUS-driven re-
ascularization (2). Therefore, it remains unclear whether IVUS-
erived measures of atherosclerosis are associated with clinical
utcomes without routine angiographic/IVUS follow-up.
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